<--- Back to Details
First PageDocument Content
Health / Pharmaceutical industry / Generic drug / Public domain / Food and Drug Administration / Pfizer / Watson Pharmaceuticals / Jon Leibowitz / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology
Date: 2015-02-26 09:49:18
Health
Pharmaceutical industry
Generic drug
Public domain
Food and Drug Administration
Pfizer
Watson Pharmaceuticals
Jon Leibowitz
Pharmaceutical sciences
Pharmaceuticals policy
Pharmacology

Court: Can drug companies pay to delay generics?

Add to Reading List

Source URL: medicalxpress.com

Download Document from Source Website

File Size: 43,37 KB

Share Document on Facebook

Similar Documents

NOVEN FILES PATENT INFRINGEMENT LAWSUIT AGAINST WATSON PHARMACEUTICALS Miami, FL and New York, NY, October 13, Noven Pharmaceuticals, Inc. announced today that it has filed a lawsuit in the U.S. District Court of

DocID: 1uSl1 - View Document

Pharmacology / Pharmaceuticals policy / Clinical pharmacology / Pharmacy / Medical prescription / Patient safety / Generic drug / Prescription medication / Electronic prescribing / Medicine / Health / Pharmaceutical sciences

15 LC 37 1893ERS (SCS) Senate Bill 51 By: Senators Burke of the 11th, Watson of the 1st, Hufstetler of the 52nd, Millar of the 40th,

DocID: 1g9L1 - View Document

Pharmacology / Pharmaceuticals policy / Clinical pharmacology / Pharmacy / Medical prescription / Patient safety / Prescription medication / Generic drug / Pharmacist / Pharmaceutical sciences / Medicine / Health

15 SB 51/AP Senate Bill 51 By: Senators Burke of the 11th, Watson of the 1st, Hufstetler of the 52nd, Millar of the 40th,

DocID: 1g9ks - View Document

Health / Pharmaceutical industry / Generic drug / Public domain / Food and Drug Administration / Pfizer / Watson Pharmaceuticals / Jon Leibowitz / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology

Court: Can drug companies pay to delay generics?

DocID: R7R5 - View Document

Presidency of Lyndon B. Johnson / Health insurance in the United States / Pharmaceuticals policy / Medicine / Medicare / Medigap / Retirement / United States National Health Care Act / Health / Federal assistance in the United States / Healthcare reform in the United States

towerswatson.com Media Contacts for Towers Watson: Rob Wyse +[removed]removed]

DocID: HdjW - View Document